AMRN

$12.05-0.66%visit website

AMARIN CORP PLC\UK

Market Cap

$5.3B

Live price × SEC shares (Oct 23, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

0.79

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Sep 2026 · negative earnings

P/S (TTM)

30.2

TTM to Sep 2026 · revenue

P/B

12.0

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	Q3 FY2026 Sep 30, 2026	TTM Sep 30, 2026
Revenue	49,219	45,132	42,211	39,550	176,112
Gross profit	23,169	17,769	14,989	16,181	72,108
Research & development	5,371	4,665	4,773	4,205	19,014
Selling, general & administrative	20,059	21,115	22,186	14,336	77,696
Total operating expenses	29,494	29,103	26,999	18,541	104,137
Operating income	(6,325)	(11,334)	(12,010)	(2,360)	(32,029)
Pretax income	(852)	(8,723)	(7,869)	315	(17,129)
Income tax	372	1,789	(219)	70	2,012
Net income	(1,224)	(10,512)	(7,650)	245	(19,141)
EPS (basic) ($)		(0.03)	(0.02)	0.00	(0.04)
EPS (diluted) ($)		(0.03)	(0.02)	0.00	(0.04)
Weighted avg. shares (basic)		419,054	416,444	417,766
Weighted avg. shares (diluted)		419,054	416,444	427,856

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Oct 28, 2026, period ended Sep 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 63 more quarters, back to Mar 2010, with Tormere Pro.

Corporate Events (8-K)

7 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Oct 28, 2026 accepted 7:05 AM ET	2.02Earnings release	Document SEC ↗
Jul 29, 2026 accepted 4:30 PM ET	2.02Earnings release	Document SEC ↗
May 15, 2026 accepted 9:30 PM ET	5.07Shareholder vote	Document SEC ↗
Apr 29, 2026 accepted 7:05 AM ET	2.02Earnings release	Document SEC ↗
Mar 27, 2026 accepted 5:00 PM ET	5.02Officer / director change	Document SEC ↗
Feb 25, 2026 accepted 7:05 AM ET	2.02Earnings release	Document SEC ↗
Jan 8, 2026 accepted 7:05 AM ET	2.02Earnings release	Document SEC ↗
Oct 29, 2025 accepted 7:05 AM ET	2.02Earnings release	Document SEC ↗
Oct 22, 2025 accepted 5:00 PM ET	5.02Officer / director change	Document SEC ↗
Jul 30, 2025 accepted 7:05 AM ET	2.02Earnings release	Document SEC ↗